« Return to News | CROs/Service Providers

PharmaNet Launches Clinical Trial Staffing Service

Thursday, March 12, 2009 09:00 AM

Despite a pending acquisition by private equity firm JLL Partners, contract research organization (CRO) PharmaNet continues to expand its service offerings and locations.

The CRO launched a new clinical trial staffing business last week, PharmaNet Resource Solutions, which will provide on-demand staffing, strategic alliances, functional service staffing and quality control services. PharmaNet opened a new office in Sao Paulo, Brazil, last month.

The new staffing division will be led by vice president Susan Seroskie. Prior to joining PharmaNet, Seroskie was senior vice president, managed services at The Clinical Resource Network. She also spent 11 years at Omnicare Clinical Research where she served as vice president, clinical operations, Americas.

"Susan brings great energy and know-how to the organization," said PharmaNet president and CEO Jeffrey P. McMullen, in a company statement. "Our solutions-based staffing business provides another entry point with large pharmaceutical clients by offering them a new alternative with PharmaNet quality built-in."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.